|
Volumn 61, Issue 2, 2001, Pages 725-731
|
Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALLYLMERCAPTOCYSTEINE;
CASPASE 3;
GARLIC EXTRACT;
GLUTATHIONE;
SULINDAC SULFIDE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CANCER CELL CULTURE;
CANCER INCIDENCE;
CANCER PREVENTION;
CARCINOGENESIS;
CELL CYCLE G1 PHASE;
CELL PROLIFERATION;
CHEMOPROPHYLAXIS;
COLON CANCER;
CONTROLLED STUDY;
GROWTH INHIBITION;
HUMAN;
HUMAN CELL;
MITOSIS;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BLOTTING, WESTERN;
CASPASE 3;
CASPASES;
CELL CYCLE;
CELL DIVISION;
CYSTEINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENZYME ACTIVATION;
G2 PHASE;
GARLIC;
GLUTATHIONE;
HT29 CELLS;
HUMANS;
IN SITU HYBRIDIZATION, FLUORESCENCE;
ISOENZYMES;
JNK MITOGEN-ACTIVATED PROTEIN KINASES;
KINETICS;
MITOGEN-ACTIVATED PROTEIN KINASES;
MITOSIS;
PLANTS, MEDICINAL;
PROTO-ONCOGENE PROTEINS C-BCL-2;
SULINDAC;
TUMOR CELLS, CULTURED;
|
EID: 0035863512
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (121)
|
References (46)
|